| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910693458503321 |
|
|
Titolo |
FDA's role in the evaluation of Avandia's safety [[electronic resource] ] : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, June 6, 2007 |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Washington : , : U.S. G.P.O., , 2009 |
|
|
|
|
|
|
|
Descrizione fisica |
|
iii, 138 pages : digital, PDF file |
|
|
|
|
|
|
Soggetti |
|
Rosiglitazone - Side effects |
Diabetes - Chemotherapy |
Drugs - United States - Testing |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Title from title screen (viewed on Mar. 20, 2009). |
Paper version available for sale by the Supt. of Docs., U.S. G.P.O. |
"Serial no. 110-76." |
|
|
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references (page 23). |
|
|
|
|
|
| |